×
About 12,855 results

ALLMedicine™ Herpes Simplex Center

Research & Reviews  4,556 results

Modified Gundersen Flap Using Inferior Palpebral-Bulbar Conjunctiva.
https://doi.org/10.1097/ICO.0000000000002823
Cornea Mekonnen B, Kossler AL et. al.

Jan 18th, 2022 - The purpose of this article was to describe a modification to the traditional Gundersen flap technique that expands eligible eyes to include those with severe conjunctival scarring and to report results from a clinical case. A 68-year-old woman wi...

Acyclovir-resistant HSV-1 keratitis: a concerning and emerging clinical challenge.
https://doi.org/10.1016/j.ajo.2022.01.010
American Journal of Ophthalmology; Rousseau A, Burrel S et. al.

Jan 17th, 2022 - Purpose To describe the clinical and virological profiles of patients with herpes simplex keratitis (HSK) caused by acyclovir-resistant (ACVR) strains of herpes simplex virus 1 (HSV-1). Design Multicenter retrospective case series. Methods HSV-1 r...

Possible association between viral infection and poor survival of the corneal graft aft...
https://doi.org/10.1136/bjophthalmol-2021-320031
The British Journal of Ophthalmology; Miao S, Lin Q et. al.

Jan 15th, 2022 - Congenital corneal opacity (CCO) is a rare disorder. Penetrating keratoplasty (PK) is the main surgical option for CCO, but many factors affect graft survival. Therefore, this study aimed to perform a virological examination of CCO specimens after...

High prevalence of sexually transmitted infections and risk factors among HIV-positive ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756631
European Journal of Medical Research; Tu W, Li YY et. al.

Jan 15th, 2022 - Yunnan has the highest rates of HIV in China. Other treatable sexually transmitted infections (STIs) are associated with accelerated HIV transmission and poor ART outcomes, but are only diagnosed by syndromic algorithms. We recruited 406 HIV-posit...

see more →

Guidelines  9 results

Management of Genital Herpes in Pregnancy: ACOG Practice Bulletinacog Practice Bulletin...
https://doi.org/10.1097/AOG.0000000000003840
Obstetrics and Gynecology;

Apr 26th, 2020 - Genital herpes simplex virus (HSV) infection during pregnancy poses a risk to the developing fetus and newborn. Genital herpes is common in the United States. Among 14- to 49-year-old females, the prevalence of HSV-2 infection is 15.9%. However, t...

Management of Genital Herpes in Pregnancy: ACOG Practice Bulletin Summary, Number 220.
https://doi.org/10.1097/AOG.0000000000003841
Obstetrics and Gynecology Reference;

Apr 26th, 2020 - Genital herpes simplex virus (HSV) infection during pregnancy poses a risk to the developing fetus and newborn. Genital herpes is common in the United States. Among 14- to 49-year-old females, the prevalence of HSV-2 infection is 15.9%. However, t...

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASC...
https://doi.org/10.1200/JCO.18.00374
Journal of Clinical Oncology : Official Journal of the Am... Taplitz RA, Kennedy EB et. al.

Sep 5th, 2018 - To provide an updated joint ASCO/Infectious Diseases Society of America (IDSA) guideline on antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its treatment. ASCO and IDSA convened an update Expert Panel...

No. 208-Guidelines for the Management of Herpes Simplex Virus in Pregnancy.
https://doi.org/10.1016/j.jogc.2017.04.016
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Money DM, Steben M

Jul 22nd, 2017 - To provide recommendations for the management of genital herpes infection in women who want to get pregnant or are pregnant and for the management of genital herpes in pregnancy and strategies to prevent transmission to the infant. More effective ...

Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Rec...
https://doi.org/10.1001/jama.2016.16776
JAMA , Bibbins-Domingo K et. al.

Dec 21st, 2016 - Genital herpes is a prevalent sexually transmitted infection in the United States, occurring in almost 1 in 6 persons aged 14 to 49 years. Infection is caused by 2 subtypes of the herpes simplex virus (HSV), HSV-1 and HSV-2. Antiviral medications ...

see more →

Drugs  130 results see all →

Clinicaltrials.gov  81 results

Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis
https://clinicaltrials.gov/ct2/show/NCT03626376

Jan 14th, 2022 - This is a prospective, randomized clinical trial looking to determine the role of prophylactic treatment with topical corticosteroids in preventing recurrences in patients with a history of infectious epithelial keratitis, stromal keratitis,endoth...

Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT)
https://clinicaltrials.gov/ct2/show/NCT04032717

Dec 30th, 2021 - A microbicide is a drug or agent designed to prevent transmission of HIV. Griffithsin, or "GRFT", is an investigational product that is being developed as a microbicide. GRFT is a naturally occurring protein originally isolated from the red alga G...

Impact of COVID-19 Infection During Pregnancy
https://clinicaltrials.gov/ct2/show/NCT05139953

Dec 1st, 2021 - COVID-19, caused by SARS-COV-2, was first reported in the city of Wuhan, Hubei province, China, at the end of December 2019. The exact origin of human infection has not yet been clearly identified.SARS-CoV-2 is a member of the Coronavirus family, ...

Effect of Autologous Cord Blood Mononuclear Cells for Prevention of Bronchopulmonary Dysplasia in Extremely Preterm Neonates
https://clinicaltrials.gov/ct2/show/NCT04440670

Nov 17th, 2021 - Study design and settings: This present study will be a randomized, placebo-controlled, double-blinded, multi-center trial to be conducted at 14 medical centers in tertiary hospitals with Neonatal Intensive Care Unit that were selected by the expe...

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
https://clinicaltrials.gov/ct2/show/NCT04950712

Nov 12th, 2021 - The aim of this study is to assess performance of using healthcare tools to understand genital Herpes Simplex Virus-2 (HSV-2) in patients ≥ 18 years of age in the United States and Europe. More specifically, the study aims to evaluate patient-repo...

see more →

News  353 results

Atopic Dermatitis and the Risk of Infections
https://www.medscape.com/viewarticle/962913

Nov 14th, 2021 - Takeaway Atopic dermatitis (AD) was associated with an increased risk of hospitalised infections, opportunistic infections and several herpesvirus infections in both children and adults, with the risk being greatest in those with severe skin disea...

European agency supports marketing of abrocitinib for atopic dermatitis
https://www.mdedge.com/dermatology/article/247470/atopic-dermatitis/european-agency-supports-marketing-abrocitinib-atopic
Elizabeth Mechcatie

Oct 15th, 2021 - The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended that the oral Janus kinase 1 inhibitor abrocitinib be granted marketing authorization in the European Union for treating atopic dermatitis (AD). Th.

European Agency Supports Marketing of Abrocitinib for Atopic Dermatitis
https://www.medscape.com/viewarticle/961004

Oct 15th, 2021 - The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended that the oral Janus kinase 1 inhibitor abrocitinib be granted marketing authorization in the European Union for treating atopic dermatitis (AD). Th...

T-VEC Delivers Durable Responses in Unresectable Melanoma
https://www.onclive.com/view/t-vec-delivers-durable-responses-in-unresectable-melanoma

Oct 6th, 2021 - Howard L. Kaufman, MD Talimogene laherparepvec (T-VEC) manifested significant gains in durable response rate (DRR) and other key clinical indicators in patients with advanced melanoma in what researchers described as the first phase III trial dem...

5 Key Areas in Emerging Immunotherapy Research Stand Out
https://www.onclive.com/view/5-key-areas-in-emerging-immunotherapy-research-stand-out

Oct 6th, 2021 - Dmitriy Zamarin, MD, PhD Although checkpoint blockade inhibitors targeting the PD-1/PD-L1 pathway are currently dominating the oncology community’s attention, there are many other exciting approaches to anticancer immunotherapy being explored in ...

see more →

Patient Education  13 results see all →